Skip to main content
. 2016 May 1;2016(5):CD012179. doi: 10.1002/14651858.CD012179

Pittaway 1989.

Study characteristics
Patient sampling Primary objective: to determine whether serum CA‐125 would be useful in differentiating between pelvic pain caused by endometriosis and that from other causes
Participants: reproductive‐aged women scheduled for laparoscopy or laparotomy for investigation of chronic pelvic pain with or without infertility
Selection criteria: inclusion criteria: reproductive age, pain lasting at least 3 months
Study design: cross‐sectional single‐gate design, prospective recruitment
Patient characteristics and setting Clinical presentation: pelvic pain ± infertility
Age: mean age 28.9 years, range 16‐39 (endometriosis) and 26.7 years, range 14‐44 years (controls)
Number of participants enrolled: 180 women
Number of participants available for analysis: 163 women (all in in late follicular phase of menstrual cycle, day 7‐10)
Setting: Section on Reproductive Endocrinilogy, Wake Forest School of Medicine, tertiary referral centre
Place of study: Winston Salem, North Carolina, USA
Period of study: over 30 months period, dates not provided
Language: English
Index tests Index test: CA‐125
Details of the index test procedure as stated: serum CA‐125 was measured in duplicate in using an immunoradiometric assay (Centocor, Malvern, PA); sample handling described, reference to a source describing laboratory technique
Threshold for positive result: CA‐125 ≥16 U/ml; pre‐specified
Examiners: no information provided; operators of index test were blinded to surgical data
Interobserver variability: not reported
Target condition and reference standard(s) Target condition: endometriosis
Prevalence of target condition in the sample: n = 82/163 (50%): stage I‐II 54, stage III‐IV 28; controls n = 81: normal pelvis ‐ 15, adhesions ‐ 27, chronic PID ‐ 28, other ‐ 11
Reference standard: laparoscopy n = 163 (100%)
Description of positive case definition by reference standard test as reported: surgical diagnosis; staging according to the rASRM classification
Examiners: no information provided; CA‐125 levels were not known at the time of surgery
Flow and timing Time interval between index test and reference standard: preoperative 7‐10 days before onset of last menses
Withdrawals: 17 women were excluded from the study (were still menstruating on a day of sample collection)
Comparative  
Key conclusions by the authors Determination of CA‐125 may assist in the evaluation and treatment of women with chronic pelvic pain
Conflict of interest Not reported
Notes The reported data enabled calculation of the diagnostic estimates per severity of endometriosis ‐ not presented in this review
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Did the study avoid inappropriate exclusions? Yes    
Was a 'two‐gate' design avoided? Yes    
    Unclear Low
DOMAIN 2: Index Test All tests
Were the index test results interpreted without knowledge of the results of the reference standard? Yes    
If a threshold was used, was it pre‐specified? Yes    
Was a cycle phase considered in interpretation of the result of index test? Yes    
    Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Yes    
    Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Yes    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
    Low